Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Buy
556
+46
+9% +$15.7K 0.1% 99
2026
Q1
$179K Sell
510
-91
-15% -$32.4K 0.1% 102
2025
Q4
$197K Sell
601
-1,021
-63% -$324K 0.11% 95
2025
Q3
$458K Sell
1,622
-6
-0.4% -$1.74K 0.17% 99
2025
Q2
$454K Sell
1,628
-157
-9% -$44.5K 0.18% 97
2025
Q1
$556K Buy
1,785
+19
+1% +$5.61K 0.23% 84
2024
Q4
$460K Sell
1,766
-104
-6% -$30.9K 0.18% 93
2024
Q3
$603K Sell
1,870
-72
-4% -$23.6K 0.24% 82
2024
Q2
$647K Sell
1,942
-56
-3% -$16.5K 0.28% 74
2024
Q1
$576K Hold
1,998
0.27% 67
2023
Q4
$576K Buy
+1,998
New +$544K 0.27% 67

Other funds holding AMGN

Sachetta's AMGN Position: Q2 2026 in Review

Sachetta increased its Amgen (AMGN) stake by 9% in Q2 2026, buying an estimated $15.7K and bringing the position to 556 shares worth $201K. The position accounts for 0.1% of the portfolio, ranked #99.

Sachetta first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $647K in Q2 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sachetta held 556 shares of Amgen worth $201K as of Q2 2026.
  • Sachetta bought 46 Amgen shares in Q2 2026, an estimated $15.7K.
  • Amgen made up 0.1% of Sachetta's portfolio in Q2 2026, its #99 holding.
  • Sachetta first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Amgen position peaked at $647K in Q2 2024.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.